District-Wise Treatment Gaps and Hospitalizations in Under-Five Children With Diarrhea in India

Sweta Dubey1, Divya Shrinivas2, Vidhi Wadhwani3

  • 1Association for Socially Applicable Research (ASAR), Pune, Maharashtra, India and Department of Pediatrics, SUNY Downstate Health Science University, New York, US.

Indian Pediatrics
|November 11, 2023
PubMed

Insights

India has the highest rates of childhood diarrhea. This study identified significant treatment gaps for oral rehydration solution and zinc, particularly in western India, highlighting areas needing improved diarrhea management for children under five.

Area of Science:

  • Pediatrics
  • Public Health
  • Global Health

Background:

  • India faces the world's highest burden of diarrhea and mortality in children under five.
  • Diarrheal diseases remain a leading cause of child mortality globally, necessitating targeted interventions.

Purpose of the Study:

  • To investigate the geographical variations in under-five diarrhea prevalence across India.
  • To identify and analyze treatment gaps for oral rehydration solution (ORS) and zinc supplementation.
  • To examine the relationship between treatment gaps and diarrheal hospitalization rates in children under five.

Main Methods:

  • Geographical analysis of under-five diarrhea prevalence.
  • Assessment of treatment gaps for ORS and zinc supplementation.
  • Statistical analysis of hospitalization rates in relation to treatment availability.

Main Results:

  • Significant geographical variations in under-five diarrhea prevalence were observed.
  • Treatment gaps for ORS and zinc supplementation were identified in specific regions, notably western Maharashtra, Andhra Pradesh, and Gujarat.
  • Diarrheal hospitalization rates were not found to be significantly associated with the identified ORS and zinc treatment gaps.

Conclusions:

  • Targeted public health interventions are crucial to address regional disparities in childhood diarrhea management.
  • Addressing treatment gaps for ORS and zinc supplementation in identified high-burden areas is essential for reducing child mortality.
  • Further research is needed to understand the factors influencing diarrheal hospitalization rates independently of treatment availability.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
128
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
186
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
105
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
192